Mice with a mutation in a target gene, such as KrasG12D mice, which have Alb-Cre-mediated somatic KRAS activation, showed iCCA-like tumor in vivo, although tumors showed low penetrance and long latency [37]. This evidence concerns the gene KRAS and neoplasm.